Charlotte McDonald

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

Zhuo Chen, Miao Feng, Andrew D. Paterson et al. · Proceedings of the National Academy of Sciences · 2016 · 238 citations · Full text

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial

Hertzel C. Gerstein, Michael E. Miller, Faramarz Ismail‐Beigi et al. · The Lancet · 2014 · 151 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +12

<i>N</i>-of-1 (Single-Patient) Trials for Statin-Related Myalgia

Tisha Joy, Alaa Monjed, Guangyong Zou et al. · Annals of Internal Medicine · 2014 · 131 citations